Kalshi

Which peptides will the FDA propose adding to the 503A Bulks List?

Before Oct 1, 2027

As of October 5, 2026, traders on Kalshi favor Semax at 77%, ahead of Epitalon at 77%. $0 traded in the last 24 hours, $2K in all.

Favorite
Semax 77%
24 hours
no change
Traded today
$0
Traded in all
$2K
Closes
October 1, 2027

Every outcome (top 6 of 7)

  1. Semax77%
  2. Epitalon77%
  3. BPC-15776%
  4. KPV76%
  5. TB-50076%
  6. MOTS-c76%

1 more outcomes, mostly long shots, are listed on Kalshi.

How the odds have moved

0%25%50%75%100%2:43 AM2:43 PM2:43 AM77% Semax

The line follows the current favorite, Semax. One reading an hour.

Embed these odds on your site

Paste this into any page. It updates every 10 minutes and links back here. Add ?theme=light or ?theme=dark to the address to fix the colors.

See this market on Kalshi →

More more politics markets

Every more politics market →

Prices are Kalshi's own (bid/ask midpoint), collected every 10 minutes. Research, not betting advice.

Data partnerLunarCrushThe Pulse, our social buzz and sentiment data, is powered by LunarCrush. How it works